Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 29 of 1,261
  1. US 12357666

    Traditional Chinese herbal plant composition for improving symptoms of liver cancer patients and compatibility method thereof

    The First Hospital of China Medical University · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  2. US 12357617

    Discovery of novel anti-infectives for gram negative pathogens

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  3. US 12357599

    Prodrugs of treprostinil

    United Therapeutics Corporation · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  4. US 12357616

    Methods of treating multiple sclerosis

    VANDA PHARMACEUTICALS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  5. US 12358979

    Antibodies that bind interleukin 13 and methods of use

    Apogee Therapeutics, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  6. US 12357615

    Compositions for the treatment of brain tumors

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  7. US 12357586

    Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  8. US 12357582

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  9. US 12358921

    Antiviral heterocyclic compounds

    Enanta Pharmaceuticals, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  10. US 12358896

    LRRK2 inhibitors and methods of making and using thereof

    DENALI THERAPEUTICS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  11. US 12358909

    Capsazepine analogs for the treatment of cancer and other proliferative diseases

    The Board of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  12. US 12358928

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  13. US 12358952

    Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds

    The Regents of the University of Colorado · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  14. US 12358863

    Nitrogen-containing derivative of substituted phenol hydroxy acid ester, and preparation and use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  15. US 12357705

    Negatively charged peg-lipid conjugates

    ARBUTUS BIOPHARMA CORPORATION · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  16. US 12357687

    Compositions and vaccines for treating and/or preventing viral infections, and methods of using the same

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  17. US 12358976

    Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d

    Ultragenyx Pharmaceutical Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  18. US 12358971

    Arena virus monoclonal antibodies and uses

    The Boad of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  19. US 12358988

    Proteolytically cleavable chimeric polypeptides and methods of use thereof

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  20. US 12359223

    Systems and methods for modulating chromosomal rearrangements

    Editas Medicine, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  21. US 12359220

    Guided magnetic nanostructures for targeted and high-throughput intracellular delivery

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  22. US 12358892

    Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and other disorders

    Miralogx LLC · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  23. US 12359204

    Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer

    The Board of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  24. US 12359178

    Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.